Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MGD024 |
Trade Name | |
Synonyms | MGD-024|MGD 024 |
Drug Descriptions |
MGD024 is a dual-affinity re-targeting (DART) molecule that targets both CD123 and CD3, which potentially leads to killing of tumor cells expressing CD123 and inhibition of tumor growth (Blood (2021) 138 (Supplement 1): 1165). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187654 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MGD024 | MGD024 | 0 | 1 |